Global provider of molecular sample and assay technologies,
) remains committed to technological advancement and new product
introductions as exhibited by its recent launch of a new DNA test
to ensure fast and reliable food testing in Europe.
The company's new DNA test can identify even finest traces of
horsemeat in food items within four hours. This is a marked
improvement over the earlier testing time of two days for a
QIAGEN has the widest range of real-time PCR test across the
industry. Its new test perfectly complements the company's
current menu of over 30 different food safety tests.
QIAGEN's latest test can be implemented across Europe to improve
food surveillance systems. The company's quick and reliable DNA
test is a stark contrast from the common test methods in Europe
in use at present - ELISA test for proteins and end-point PCR
test for DNA. While both test are inconvenient and lack common
test standards, ELISA also cannot be used for processed food.
The DNA test is likely to address the ongoing problem of testing
the authenticity of raw and processed foods in Europe. Further,
it also standardizes testing across Europe.
Concerns about food safety and authenticity prompted the company
to address the issue in the interest of the consumer. Considering
the utility of this new DNA test, we are optimistic that it will
garner incremental revenues for the company.
The stock carries a Zacks Rank #3 (Hold). While we remain on the
sidelines for QIAGEN, other healthcare stocks such as
) warrant a look. These stocks carry a Zacks Rank #2 (Buy).
ABAXIS INC (ABAX): Free Stock Analysis Report
COVIDIEN PLC (COV): Free Stock Analysis
CONCEPTUS INC (CPTS): Free Stock Analysis
QIAGEN NV (QGEN): Free Stock Analysis Report
To read this article on Zacks.com click here.